SK bioscience submits application for NVX-CoV2373, the first protein-based COVID-19 vaccine candidate for BLA, to South Korea's MFDS
GAITHERSBURG, Md., Nov. 15, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation...
50 microgram matrix m adjuvant
chief executive officer novavax
chief executive officer sk bioscience
coronavirusspikesprotein
country: unknown
novavax' recombinant nanoparticle technology
protein based vaccine candidate
saponin based matrix m adjuvant
stanley c erck president
two pivotal phase 3 trials
